ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Translational Session

New Directions and Strategies to Improve Hypertension and Pain Management in CKD

November 03, 2022 | 02:00 PM - 04:00 PM

Location: W415 Valencia, Orange County Convention Center‚ West Building

Session Description

Patients with CKD often have uncontrolled hypertension despite a plethora of antihypertensive agents. African Americans have a higher prevalence of uncontrolled hypertension. Patients with CKD can experience uncontrolled pain requiring opioids. This session focuses on new strategies for improving hypertension and opioid pain management in CKD. Presenters show the emerging role of genomic and pharmacogenomic testing for hypertension management in CKD and describe the implementation of pharmacogenomic testing for both hypertension management and pain control.

Learning Objective(s)

  • Explain the emerging role of genomics and pharmacogenomics in hypertension management in CKD
  • Discuss the feasibility and challenges of implementing genomic testing for hypertension management
  • Determine the feasibility and challenges of implementing pharmacogenomic testing in clinical practice
  • Describe evidence supporting the use of pharmacogenetics to guide opioid use and applications in the practice setting

Learning Pathway(s)

  • CKD Non-Dialysis
  • Pharmacology


  • Linda Awdishu, PharmD, FASN
  • Adriana Hung, MD, MPH